I agree that this site is using cookies. You can find further informations here.
X
Girard, N
3092  results:
Search for persons X
?
1

2MO Amivantamab plus chemotherapy vs chemotherapy as first-..:

Felip, E. ; Shu, C.A. ; Aguilar, A....
ESMO Open.  9 (2024)  - p. 102581 , 2024
Link: https://doi.org/10.1016/..
 
?
2

59P Datopotamab deruxtecan (Dato-DXd) in patients with prev..:

Girard, N. ; Okamoto, I. ; Lisberg, A.E....
ESMO Open.  9 (2024)  - p. 102638 , 2024
Link: https://doi.org/10.1016/..
 
?
3

5MO Effect of amivantamab dose interruptions on efficacy an..:

García Campelo, M.R. ; Cho, B.C. ; Girard, N....
ESMO Open.  9 (2024)  - p. 102584 , 2024
Link: https://doi.org/10.1016/..
 
?
4

31P Myelosuppression risk from epidermal growth factor rece..:

Girard, N. ; Liu, S.V. ; Nassib William Junior, W....
ESMO Open.  9 (2024)  - p. 102610 , 2024
Link: https://doi.org/10.1016/..
 
?
5

#17. Evolution of epidemiology of bone metastasis in France..:

Belhassen, M ; Marchal, Ca ; Walter, Ma...
Journal of Bone Oncology.  45 (2024)  - p. 100555 , 2024
Link: https://doi.org/10.1016/..
 
?
6

7P Patient-relevant endpoints from PAPILLON: Amivantamab pl..:

Paz-Ares, L. ; Veillon, R. ; Majem, M....
ESMO Open.  9 (2024)  - p. 102586 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Amivantamab plus chemotherapy with and without lazertinib i..:

Passaro, A. ; Wang, J. ; Wang, Y....
Annals of Oncology.  35 (2024)  1 - p. 77-90 , 2024
Link: https://doi.org/10.1016/..
 
?
8

First upper limits on the 21 cm signal power spectrum from ..:

Munshi, S. ; Mertens, F. G. ; Koopmans, L. V. E....
Astronomy & Astrophysics.  687 (2024)  - p. C1 , 2024
Link: https://doi.org/10.1051/..
 
?
9

Palliative care integration and end-of-life care intensity ..:

Martin, A. ; Carton, M. ; Thery, L....
Lung Cancer.  192 (2024)  - p. 107800 , 2024
Link: https://doi.org/10.1016/..
 
?
10

Clinical characteristic and survival outcomes of patients w..:

Thomas, Q.D. ; Quantin, X. ; Lemercier, P....
ESMO Open.  9 (2024)  6 - p. 103473 , 2024
Link: https://doi.org/10.1016/..
 
?
11

Real-world outcomes with durvalumab after chemoradiotherapy..:

Filippi, A.R. ; Bar, J. ; Chouaid, C....
ESMO Open.  9 (2024)  6 - p. 103464 , 2024
Link: https://doi.org/10.1016/..
 
?
12

A General Method For The Diagnosis Of Wind Turbine Systemat..:

Astolfi, D ; Pasetti, M ; Lombardi, A...
Journal of Physics: Conference Series.  2767 (2024)  4 - p. 042007 , 2024
Link: https://doi.org/10.1088/..
 
?
13

Amivantamab plus lazertinib versus osimertinib in first-lin..:

Felip, E. ; Cho, B.C. ; Gutiérrez, V....
Annals of Oncology.  , 2024
Link: https://doi.org/10.1016/..
 
?
14

First upper limits on the 21 cm signal power spectrum from ..:

Munshi, S. ; Mertens, F. G. ; Koopmans, L. V. E....
Astronomy & Astrophysics.  681 (2024)  - p. A62 , 2024
Link: https://doi.org/10.1051/..
 
?
15

OA17.03 Real-World Outcomes with Durvalumab After Chemoradi..:

Peters, S. ; Christoph, D.C. ; Field, J.K....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S83 , 2023
Link: https://doi.org/10.1016/..
 
1-15